Sarissa Capital Management’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-1,025,000
| Closed | -$3.03M | – | 11 |
|
|
2018
Q3 | $3.03M | Hold |
1,025,000
| – | – | 0.67% | 7 |
|
|
2018
Q2 | $3.77M | Hold |
1,025,000
| – | – | 0.76% | 8 |
|
|
2018
Q1 | $3.59M | Hold |
1,025,000
| – | – | 0.83% | 8 |
|
|
2017
Q4 | $3.2M | Hold |
1,025,000
| – | – | 0.82% | 9 |
|
|
2017
Q3 | $7.21M | Hold |
1,025,000
| – | – | 2.22% | 6 |
|
|
2017
Q2 | $9.46M | Hold |
1,025,000
| – | – | 3.16% | 5 |
|
|
2017
Q1 | $11M | Hold |
1,025,000
| – | – | 4.35% | 4 |
|
|
2016
Q4 | $8.63M | Buy |
+1,025,000
| New | +$8.63M | 2.38% | 5 |
|